title: Meeting report: primary central nervous system lymphoma: standards of care and future perspectives.
abstract: A standard of care for patients with primary central nervous system lymphoma (PCNSL) has not been defined. Current controversies concern, amongst others, the role, dose and timing of radiotherapy, the role of intrathecal chemotherapy and the delineation of age-specific standards of care. Given the strong clinical trial activities for PCNSL in Germany, the PCNSL conference held in Tubingen aimed at comparing the diverging trial strategies in Germany and at exploring the options for joint activities of the various PCNSL study groups in the near future.
authors.affiliation: Abteilung für Allgemeine Neurologie, Hertie-Institut für Klinische Hirnforschung, Zentrum für Neurologie, Universität Tübingen, Germany. ulrich.herrlinger@uni-tuebingen.de
authors.forename: Ulrich
authors.initials: U
authors.lastname: Herrlinger
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Korfel
authors.forename: Holger
authors.initials: H
authors.lastname: Hebart
authors.forename: Uwe
authors.initials: U
authors.lastname: Schlegel
authors.forename: Ludwig
authors.initials: L
authors.lastname: Plasswilm
authors.forename: Gerald
authors.initials: G
authors.lastname: Illerhaus
authors.forename: Jürgen
authors.initials: J
authors.lastname: Finke
authors.forename: William
authors.initials: W
authors.lastname: Krüger
authors.forename: Michael
authors.initials: M
authors.lastname: Montemurro
authors.forename: Timo
authors.initials: T
authors.lastname: Wolf
authors.forename: Eckhart
authors.initials: E
authors.lastname: Thiel
authors.forename: Michael
authors.initials: M
authors.lastname: Bamberg
authors.forename: Michael
authors.initials: M
authors.lastname: Weller
authors.forename: Lothar
authors.initials: L
authors.lastname: Kanz
mesh_terms: D000970:Antineoplastic Agents / Q000145:classification / Q000592:standards / Q000627:therapeutic use*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005858:Germany; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards / Q000639:trends*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents